# Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study

> **NCT06887270** · NA · NOT_YET_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 10 (estimated)

## Conditions studied

- Anticoagulant-induced Bleeding
- Direct Oral Anticoagulant
- Cancer
- Central Venous Catheter
- Periprocedural Complication

## Interventions

- **OTHER:** Continued DOAC
- **OTHER:** Interrupted DOAC

## Key facts

- **NCT ID:** NCT06887270
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-03-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06887270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06887270, "Peri-procedural Management of Direct Oral Anticoagulants for Central VENOus Catheters in CAncer Patients With Venous Thromboembolism or Atrial Fibrillation Pilot Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06887270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*